Die Tumeszenzlokalanästhesie in der Varizenchirurgie

Die Tumeszenzlokalanästhesie (TLA) wird seit Anfang der 1990er Jahre im Bereich der Phlebochirurgie eingesetzt. Sämtliche Routineeingriffe (inguinale und popliteale Krossektomien, Exhairese der V. saphena magna /parva, lokale Phlebektomien, Perforans-Ligaturen, minichirurgische Phlebektomien ) können problemlos in TLA mittels einer mechanischen Rollpumpe erfolgen. Auch erschwerte Operationen wie inguinale bzw. popliteale Krossenrevisionen, Befunde mit (sub)akuten Thrombophlebitiden oder Eingriffe bei Dermatoliposklerose und Ulcus cruris venosum können mit dieser Technik teils in Kombination mit einer intravenösen Anästhesie durchgeführt werden.

Vorteile der TLA sind die unkomplizierte Applikation, die sofort einsetzende und postoperativ langanhaltende Analgesie, die reduzierte intraoperative Blutungsneigung und konsekutiv reduzierte postoperative Hämatombildung, das minimale Thrombose- und Embolierisikio, die antibakterielle Wirkung sowie die durch den so genannten Hydrodissektionseffekt erleichtere Präparation. Die TLA stellt eine sichere, komfortable und wirkungsvolle Methode der Lokalanästhesie in der Phlebochirurgie ohne die Nachteile anderer Anästhesieformen dar.

Protecting effect of PrP codons M142 and K222 in goats orally challenged with bovine spongiform encephalopathy prions

Breeding towards genetic resistance to prion disease is effective in eliminating scrapie. In sheep, classical forms of scrapie have been eradicated almost completely in several countries by breeding programs using a prion protein (PrP) gene (PRNP) amino acid polymorphism. For goats, field and experimental studies have provided evidence for several amino acid polymorphisms that are associated with resistance to scrapie, but only limited data are available concerning the susceptibility of caprine PRNP genotypes to BSE. In this study, goat kids representing five PRNP genotypes based on three polymorphisms (M142, Q211 and K222 and the wild type I142, R211 and Q222) were orally challenged with bovine or goat BSE. Wild type goats were killed with clinical signs between 24-28 months post inoculation (mpi) to both challenges, and goats with genotype R/Q211 succumbed between 29-36 mpi. I/M142 goats developed clinical signs at 44-45 mpi and M/M142 goats remained healthy until euthanasia at 48 mpi. None of the Q/K222 goats showed definite clinical signs. Taken together the highest attack ratios were seen in wild type and R/Q211 goats, and the lowest in I/M142, M/M142 and Q/K222. In all genotype groups, one or more goats remained healthy within the incubation period in both challenges and without detectable PrP deposition in the tissues. Our data show that both the K222 and M142 polymorphisms lengthen the incubation period significantly compared to wild type animals, but only K222 was associated with a significant increase in resistance to BSE infection after oral exposure to both BSE sources.

Experimental Infection of Calves with Escherichia coli O104:H4 outbreak strain

In 2011, a severe outbreak of hemolytic-uremic syndrome was caused by an unusual, highly virulent enterohemorrhagic E. coli (EHEC) O104:H4 strain, which possessed EHEC virulence traits in the genetic background of human-adapted enteroaggregative E. coli. To determine magnitude of fecal shedding and site of colonization of EHEC O104:H4 in a livestock host, 30 (ten/strain) weaned calves were inoculated with 10¹⁰ CFU of EHEC O104:H4, EHEC O157:H7 (positive control) or E. coli strain 123 (negative control) and necropsied (4 or 28 d.p.i.). E. coli O157:H7 was recovered until 28 d.p.i. and O104:H4 until 24 d.p.i. At 4 d.p.i., EHEC O104:H4 was isolated from intestinal content and detected associated with the intestinal mucosa. These results are the first evidence that cattle, the most important EHEC reservoir, can also carry unusual EHEC strains at least transiently, questioning our current understanding of the molecular basis of host adaptation of this important E. coli pathovar.

Histopathological and Immunohistochemical Studies of Cowpox Virus Replication in a Three-Dimensional Skin Model

Human cowpox virus (CPXV) infections are rare, but can result in severe and sometimes fatal outcomes. The majority of recent cases were traced back to contacts with infected domestic cats or pet rats. The aim of the present study was to evaluate a three-dimensional (3D) skin model as a possible replacement for animal experiments. We monitored CPXV lesion formation, viral gene expression and cell cycle patterns after infection of 3D skin cultures with two CPXV strains of different pathogenic potential: a recent pet rat isolate (RatPox09) and the reference Brighton red strain. Infected 3D skin cultures exhibited histological alterations that were similar to those of mammal skin infections, but there were no differences in gene expression patterns and tissue damage between the two CPXV strains in the model system. In conclusion, 3D skin cultures reflect the development of pox lesions in the skin very well, but seem not to allow differentiation between more or less virulent virus strains, a distinction that is made possible by experimental infection in suitable animal models.